Show simple item record

dc.contributor.authorGedawy, Ahmed Abou Bakr Gaber
dc.contributor.supervisorCrispin Dassen_US
dc.contributor.supervisorHani Al-Salamien_US
dc.date.accessioned2020-12-07T04:31:44Z
dc.date.available2020-12-07T04:31:44Z
dc.date.issued2020en_US
dc.identifier.urihttp://hdl.handle.net/20.500.11937/81966
dc.description.abstract

This thesis is divided into two main sections. The first section is about developing of silicon-based pharmaceutical platform that was used to encapsulate an anti-diabetic agent (metformin). These developed microcapsules were then characterised in terms of drug content, encapsulation efficiency, flow properties and microscopical examination. The second section is about development and validation of a new HPLC analytical method for the detection and quantification of metformin and two other anti-diabetic agents that belong to sulfonylureas.

en_US
dc.publisherCurtin Universityen_US
dc.titleInnovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabeticsen_US
dc.typeThesisen_US
dcterms.educationLevelMPhilen_US
curtin.departmentSchool of Pharmacy and Biomedical Sciencesen_US
curtin.departmentBiotechnology and Drug Development Research Laboratoryen_US
curtin.departmentCurtin Health Innovation Research Instituteen_US
curtin.accessStatusOpen accessen_US
curtin.facultyHealth Sciencesen_US
curtin.contributor.orcidGedawy, Ahmed Abou Bakr Gaber [0000-0003-1568-5455]en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record